← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2010Last known activity
Apr 12, 2016
Defunct as of Jan 31, 2021
Timeline
2000s
- Jun 1, 2008
OHR Pharmaceutical— Founded
2020s
- Jan 31, 2021
OHR Pharmaceutical— Defunct
Drugs by trial phase (3 distinct, 6 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT02727881Study directorPhase 3Apr 12, 2016
- NCT02727881Lead sponsorPhase 3Apr 12, 2016
- NCT02511613Lead sponsorPhase 2Jul 1, 2015
- NCT02511613Study directorPhase 2Jul 1, 2015
- NCT02349516CollaboratorPhase 2Feb 1, 2015
- NCT02614937Lead sponsorPhase 1/Phase 2Apr 1, 2013
- NCT01678963Lead sponsorPhase 2Nov 1, 2012
- NCT01206335Lead sponsorPhase 2Sep 1, 2010
Details
- Founded
- New York, NY, US Jun 1, 2008
- Last known activity
- Apr 12, 2016
Notes
--- Pre-folding founded info: 2009-06-01 New York NY United States https://www.owler.com/company/ohrpharmaceutical --- No website as of Jan 2021